NEW YORK STEM CELL SUMMIT: 2014 PREVIEW (Orthopedics This Week)
Sales of stem cell products in 2013 skyrocketed, we estimate, 42% from 2012 to reach $236 million. With several new players entering the market, notably DePuy Synthes (the largest orthopedic company in the world), stem cell sales will accelerate, we estimate, by 61% to reach an eventual sales amount of $380 million. The principal driver of these sales will be improved versions of the cancellous bone with endogenous mesenchymal stem cells (MSCs), new allograft liquid forms with endogenous MSCs for orthopedic use and sharply rising ...
